• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响弥漫性皮肤系统性硬化症患者早期转介、早期诊断和治疗的因素。

Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis.

机构信息

Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.

Immunogenetics, Cochin Institute, Paris, France.

出版信息

Rheumatology (Oxford). 2018 May 1;57(5):813-817. doi: 10.1093/rheumatology/kex504.

DOI:10.1093/rheumatology/kex504
PMID:29415230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5913641/
Abstract

OBJECTIVE

To gain insight into clinical practice regarding referral, early diagnosis and other aspects of the management of patients with dcSSc in Europe and the USA.

METHODS

Semi-structured interviews were conducted with 84 rheumatologists (or internal medicine physicians) and 40 dermatologists in different countries (the UK, France, Germany, Italy, Spain and the USA). Physicians were asked to identify key steps in the patient pathway relating to patient presentation, diagnosis and referral, in addition to other treatment and follow-up processes.

RESULTS

The interviewed physicians reported that late presentation with dcSSc was common, with some patients presenting to primary care physicians after symptoms had persisted for up to 1 year. Awareness of dcSSc is reported to vary widely among primary care physicians. Final diagnosis, generally following guideline-based recommendations, was by rheumatologists in most cases (or internal medicine physicians in France) and they remained responsible for global patient management, with lesser involvement in diagnosis and management by dermatologists. Specialist centres were not well defined and did not exist in all countries.

CONCLUSION

Patients and primary healthcare providers can be unaware of the symptoms of dcSSc, therefore presentation and referral to specialist care are often late. Thus, improved awareness among patients and primary care physicians is necessary to facilitate earlier referral and diagnosis. Once referred, more consistent use of the modified Rodnan skin score at diagnosis and follow-up may help to monitor disease progression. Furthermore, establishing specialist centres may help to promote such changes and improve patient care.

摘要

目的

深入了解欧洲和美国在硬皮病患者转诊、早期诊断及其他方面的管理实践。

方法

对来自不同国家(英国、法国、德国、意大利、西班牙和美国)的 84 名风湿病学家(或内科医生)和 40 名皮肤科医生进行半结构式访谈。要求医生识别患者就诊、诊断和转诊相关的关键步骤,以及其他治疗和随访流程。

结果

受访医生报告称,硬皮病患者就诊时间较晚较为常见,一些患者在症状持续长达 1 年后才到初级保健医生处就诊。初级保健医生对硬皮病的认识差异很大。根据指南推荐的最终诊断通常由风湿病学家(或法国的内科医生)做出,他们负责患者的全面管理,皮肤科医生在诊断和管理方面的参与度较低。专业中心的定义不明确,并非所有国家都设有专业中心。

结论

患者和初级保健提供者可能对硬皮病的症状不了解,因此就诊和转诊至专科治疗往往较晚。因此,需要提高患者和初级保健医生的认识,以促进更早的转诊和诊断。一旦转诊,在诊断和随访时更一致地使用改良 Rodnan 皮肤评分可能有助于监测疾病进展。此外,建立专业中心可能有助于推动这些变化并改善患者的护理。

相似文献

1
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis.影响弥漫性皮肤系统性硬化症患者早期转介、早期诊断和治疗的因素。
Rheumatology (Oxford). 2018 May 1;57(5):813-817. doi: 10.1093/rheumatology/kex504.
2
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey.中轴型脊柱关节炎患者的转诊模式、诊断及疾病管理:一项国际调查结果
J Clin Rheumatol. 2014 Dec;20(8):411-7. doi: 10.1097/RHU.0000000000000180.
3
Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need.早期弥漫性皮肤型系统性硬化症中的皮肤受累:一项未满足的临床需求。
Nat Rev Rheumatol. 2022 May;18(5):276-285. doi: 10.1038/s41584-022-00765-9. Epub 2022 Mar 15.
4
Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.无硬皮病的系统性硬化症:1417例受试者的多中心研究。
J Rheumatol. 2014 Nov;41(11):2179-85. doi: 10.3899/jrheum.140236. Epub 2014 Oct 1.
5
The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.全球早期类风湿关节炎的诊疗现状:一项多国横断面调查的结果
Clin Exp Rheumatol. 2017 May-Jun;35(3):477-483. Epub 2017 Jan 27.
6
Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.医生对非黑色素瘤皮肤癌(NMSC)和光化性角化病(AK)的知晓情况、了解程度及态度。
Int J Dermatol. 2004 Sep;43(9):638-42. doi: 10.1111/j.1365-4632.2004.02124.x.
7
Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.皮肤色素减退和色素沉着在弥漫性皮肤型系统性硬化症中的临床应用
Int J Rheum Dis. 2017 Jun;20(6):767-773. doi: 10.1111/1756-185X.13049. Epub 2017 Mar 6.
8
The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.在全科医疗中,直接转诊进行快速CT扫描对早期肺癌检测的效果。一项临床、整群随机试验。
Dan Med J. 2015 Mar;62(3).
9
Dental screening and referral of young children by pediatric primary care providers.儿科初级保健提供者对幼儿进行牙科筛查和转诊。
Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269.
10
An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation.一种仅使用首发症状的时间和类型以及自身抗体来预测弥漫性皮肤系统性硬化症的简易规则:推导与验证
Rheumatology (Oxford). 2016 Nov;55(11):2023-2032. doi: 10.1093/rheumatology/kew305. Epub 2016 Aug 21.

引用本文的文献

1
Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis.血管内皮生长因子作为系统性硬化症的潜在生物标志物:一项系统评价和荟萃分析。
Front Immunol. 2024 Nov 28;15:1442913. doi: 10.3389/fimmu.2024.1442913. eCollection 2024.
2
Living with Systemic Sclerosis: A Patient and Physician Perspective.系统性硬化症患者与医生视角:共同面对
Rheumatol Ther. 2023 Aug;10(4):785-792. doi: 10.1007/s40744-023-00555-z. Epub 2023 May 13.
3
Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study.

本文引用的文献

1
2016 update of the EULAR recommendations for the management of early arthritis.2016 年更新版的 EULAR 早期关节炎管理建议。
Ann Rheum Dis. 2017 Jun;76(6):948-959. doi: 10.1136/annrheumdis-2016-210602. Epub 2016 Dec 15.
2
Update of EULAR recommendations for the treatment of systemic sclerosis.EULAR 系统性硬皮病治疗推荐更新。
Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.
3
BSR and BHPR guideline for the treatment of systemic sclerosis.英国风湿病学会和英国卫生与保健改善署系统性硬化症治疗指南
了解系统性硬化症和系统性硬化症相关间质性肺病的诊断途径:一项回顾性队列研究。
Medicine (Baltimore). 2022 Aug 12;101(32):e29993. doi: 10.1097/MD.0000000000029993.
4
Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need.早期弥漫性皮肤型系统性硬化症中的皮肤受累:一项未满足的临床需求。
Nat Rev Rheumatol. 2022 May;18(5):276-285. doi: 10.1038/s41584-022-00765-9. Epub 2022 Mar 15.
5
Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease.自体造血干细胞移植与系统性硬化症:关注间质性肺病。
Cells. 2022 Mar 1;11(5):843. doi: 10.3390/cells11050843.
6
Pulmonary hypertension phenotypes in patients with systemic sclerosis.系统性硬皮病患者的肺动脉高压表型。
Eur Respir Rev. 2021 Aug 17;30(161). doi: 10.1183/16000617.0053-2021. Print 2021 Sep 30.
7
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews.通过半定性深入访谈识别 SSc-ILD 的未满足需求。
Rheumatology (Oxford). 2021 Dec 1;60(12):5601-5609. doi: 10.1093/rheumatology/keab154.
8
Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations.患者组织与临床研究赞助商在罕见病情况下的合作:从社区咨询委员会获得的经验教训和未来合作的最佳实践。
BMJ Open. 2020 Dec 16;10(12):e039473. doi: 10.1136/bmjopen-2020-039473.
9
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort.多维度追踪表型和器官受累在一个完整的全国系统性硬化症队列。
Rheumatology (Oxford). 2020 Oct 1;59(10):2920-2929. doi: 10.1093/rheumatology/keaa026.
10
Predictors of progression in systemic sclerosis patients with interstitial lung disease.系统性硬皮病合并间质性肺病患者进展的预测因素。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.02026-2019. Print 2020 May.
Rheumatology (Oxford). 2016 Oct;55(10):1906-10. doi: 10.1093/rheumatology/kew224. Epub 2016 Jun 9.
4
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis.弥漫性皮肤系统性硬化症皮肤纤维化改善情况的预测:一项欧洲抗风湿病联盟系统性硬化症注册研究(EUSTAR)分析
Ann Rheum Dis. 2016 Oct;75(10):1743-8. doi: 10.1136/annrheumdis-2015-208024. Epub 2016 Mar 25.
5
Prediction of pulmonary complications and long-term survival in systemic sclerosis.系统性硬化症肺部并发症及长期生存预测。
Arthritis Rheumatol. 2014 Jun;66(6):1625-35. doi: 10.1002/art.38390.
6
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.2013年系统性硬化症分类标准:美国风湿病学会/欧洲抗风湿病联盟合作倡议
Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3.
7
Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.系统性硬皮病的生存、死因和预后因素:947 例巴西患者分析。
J Rheumatol. 2012 Oct;39(10):1971-8. doi: 10.3899/jrheum.111582. Epub 2012 Aug 15.
8
An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis.美国三级保健中心结缔组织病相关间质性肺疾病分析:系统性硬化症患者的生存率更好。
J Rheumatol. 2011 Apr;38(4):693-701. doi: 10.3899/jrheum.100675. Epub 2011 Feb 1.
9
Determinants of morbidity and mortality of systemic sclerosis in Canada.加拿大系统性硬化症发病率和死亡率的决定因素。
Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15.
10
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.弥漫性皮肤系统性硬化症中皮肤评分变化与疾病转归的关系:潜在线性轨迹模型的应用
Arthritis Rheum. 2007 Jul;56(7):2422-31. doi: 10.1002/art.22721.